Renovis Surgical Receives FDA Clearance for Tesera Trabecular Technology(TM) Hyperlordotic ALIF Interbody Spinal Fusion System

REDLANDS, Calif. and AUSTIN, Texas, June 28, 2018 -- (Healthcare Sales & Marketing Network) -- Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera&... Devices, Orthopaedic, Neurosurgery, FDA Renovis Surgical Technologies, Tesera, Hyperlordotic, Spinal Fusion

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2044048

Source: HSMN NewsFeed - June 28, 2018 Category: Pharmaceuticals Source Type: news